Forte Biosciences

(NASDAQ) FBRX

Current Price$26.24

Market Cap$519.68M

Since IPO (2020)-94%

5 Year-97%

1 Year+323%

1 Month+0%

Forte Biosciences Financials at a Glance

Market Cap

$519.68M

Revenue (TTM)

$0.00

Net Income (TTM)

$69.38M

EPS (TTM)

$-5.24

P/E Ratio

-5.06

Dividend

$0.00

Beta (Volatility)

0.79 (Low)

Dividend

$0.00

Beta (Volatility)

0.79 (Low)

Price

$26.24

Volume

8,425

Open

$26.50

Price

$26.24

Volume

8,425

Open

$26.50

Previous Close

$26.24

Daily Range

$25.74 - $27.05

52-Week Range

$6.19 - $35.80

Dividend

$0.00

Beta (Volatility)

0.79 (Low)

Price

$26.24

Volume

8,425

Open

$26.50

Previous Close

$26.24

Daily Range

$25.74 - $27.05

52-Week Range

$6.19 - $35.80

FBRX News

Forte Biosciences Tops Q2 Loss Forecasts

Motley Fool Markets TeamAug 14, 2025

Why Forte Biosciences Stock Is Imploding Today

Keith SpeightsSep 3, 2021

FBRX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Forte Biosciences

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Paul A. Wagner, PhD, CFA

Website

www.fortebiorx.com

Headquarters

Dallas, TX 75247, US

FBRX Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-122%

Return on Capital

-1%

Return on Assets

-84%

Earnings Yield

-19.76%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$519.68M

Shares Outstanding

19.60M

Volume

8.43K

Avg. Volume

275.61K

Financials (TTM)

Gross Profit

$64.00K

Operating Income

$70.66M

EBITDA

$70.59M

Operating Cash Flow

$50.88M

Capital Expenditure

$116.00K

Free Cash Flow

$51.00M

Cash & ST Invst.

$76.96M

Total Debt

$0.00

Forte Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$45.00K

+550.0%

Gross Margin

0.00%

N/A

Market Cap

$519.68M

N/A

Market Cap/Employee

$37.12M

N/A

Employees

N/A

Net Income

$24.79M

-246.4%

EBITDA

$24.55M

-243.6%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$76.96M

+31.9%

Accounts Receivable

$817.00K

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-83.81%

N/A

Return on Invested Capital

-1.14%

N/A

Free Cash Flow

$16.47M

-64.0%

Operating Cash Flow

$16.47M

-64.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

FATEFate Therapeutics, Inc.

FATEFate Therapeutics, Inc.$2.43+6.11%

ALECAlector, Inc.

ALECAlector, Inc.$2.44-5.06%

NKTXNkarta, Inc.

NKTXNkarta, Inc.$3.15-5.12%

ELTXElicio Therapeutics, Inc.

ELTXElicio Therapeutics, Inc.$10.01-4.21%

MOLNMolecular Partners AG

MOLNMolecular Partners AG$4.10-4.33%

CRBPCorbus Pharmaceuticals Holdings, Inc.

CRBPCorbus Pharmaceuticals Holdings, Inc.$10.87-0.46%

PEPGPepGen Inc.

PEPGPepGen Inc.$1.79-2.98%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.47+0.07%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$71.34-0.00%

SNAPSnap

SNAPSnap$5.98-0.02%

ATRAAtara Biotherapeutics

ATRAAtara Biotherapeutics$9.93+0.93%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$45.73+0.00%

ACHRArcher Aviation

ACHRArcher Aviation$6.28-0.02%

SOFISoFi Technologies

SOFISoFi Technologies$16.00-0.02%

Questions About FBRX

What is the current price of Forte Biosciences?

Forte Biosciences is trading at $26.24 per share.

What is the 52-week range for Forte Biosciences?

Over the past 52 weeks, Forte Biosciences has traded between $6.19 and $35.80.

How much debt does Forte Biosciences have?

As of the most recent reporting period, Forte Biosciences reported total debt of N/A.

How much cash does Forte Biosciences have on hand?

Forte Biosciences reported $76.96M in cash and cash equivalents in its most recent financial results.

What is Forte Biosciences’s dividend yield?

Forte Biosciences does not currently have a dividend yield.

Forte Biosciences

Forte Biosciences Financials at a Glance

FBRX News

Forte Biosciences Tops Q2 Loss Forecasts

Why Forte Biosciences Stock Is Imploding Today

FBRX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Forte Biosciences

FBRX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Forte Biosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About FBRX

What is the current price of Forte Biosciences?

What is the 52-week range for Forte Biosciences?

How much debt does Forte Biosciences have?

How much cash does Forte Biosciences have on hand?

What is Forte Biosciences’s dividend yield?

Premium Investing Services